Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
309 studies found for:    glioblastoma | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy
Condition: Glioblastoma Multiforme
Interventions: Drug: TPI 287;   Drug: Bevacizumab
22 Recruiting Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.
Condition: Glioblastoma Multiforme
Intervention: Drug: H-1PV
23 Unknown  Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma
Conditions: Glioblastomas;   Gliosarcoma
Intervention: Other: Hyperbaric Oxygen Therapy
24 Recruiting A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma
Condition: Glioblastoma
Interventions: Other: Chemoradiation Therapy;   Other: Adjuvant Therapy
25 Recruiting Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: TPI 287;   Drug: Bevacizumab
26 Not yet recruiting Early-Phase Study to Assess Inhibitor LEE011 in Patients With Recurrent Glioblastoma or Anaplastic Glioma
Conditions: Glioblastoma;   Glioma
Intervention: Drug: LEE011
27 Recruiting Prevention of Thrombocytopenia in Glioblastoma Patients
Conditions: Thrombocytopenia,;   Glioblastoma
Intervention: Drug: Romiplostim
28 Unknown  AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Drug: AQ4N;   Drug: Temozolomide;   Procedure: Radiotherapy
29 Recruiting FMISO PET Study of Glioblastoma
Condition: Recurrent Glioblastoma
Interventions: Device: FMISO PET;   Device: MRI;   Drug: Bevacizumab
30 Not yet recruiting Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioblastoma
Conditions: Glioblastoma;   Astrocytoma
Intervention: Radiation: Rhenium Liposome Treatment
31 Recruiting A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma
Condition: Glioblastoma Multiforme
Intervention: Biological: ICT-121 DC vaccine
32 Unknown  Procarbazine and Lomustine in Recurrent Glioblastoma
Condition: Recurrent Glioblastoma Multiforme
Intervention: Drug: lomustine and procarbazine
33 Unknown  Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma
Condition: Glioblastoma Multiforme/Anaplastic Astrocytoma
Interventions: Drug: temozolomide;   Radiation: radiation therapy;   Radiation: stereotactic radiotherapy
34 Not yet recruiting Trial of Hypofractionated Radiation Therapy for Glioblastoma
Condition: Glioblastoma
Interventions: Radiation: Hypofractionated radiation therapy;   Radiation: Standard radiation therapy
35 Recruiting Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma
Condition: Glioblastoma
Interventions: Radiation: Radiotherapy;   Radiation: Experimental arm
36 Not yet recruiting Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme
Conditions: Glioblastoma Multiforme;   Glioblastoma - Category
Interventions: Drug: Bevacizumab;   Procedure: Magnetic Resonance Spectroscopy (MRS);   Procedure: Border Zone Stereotactic Radiosurgery (BZ-SRS)
37 Unknown  Study of DC Vaccination Against Glioblastoma
Conditions: Glioma;   Glioblastoma Multiforme;   Neoplasms
Interventions: Procedure: Surgery;   Drug: Chemotherapy;   Radiation: Radiotherapy;   Biological: DC vaccination;   Drug: blank placebo
38 Recruiting Ph I Personalized NeoAntigen Cancer Vaccine With Radiotherapy for Patients With MGMT Unmethylated, Newly Diagnosed Glioblastoma
Conditions: Glioblastoma;   MGMT-unmethylated Glioblastoma;   Gliosarcoma;   Glioblastoma With Oligodendroglial Features;   Giant Cell Glioblastoma;   Glioblastoma Multiforme
Interventions: Radiation: Radiation Therapy;   Biological: Personalized NeoAntigen Vaccine
39 Recruiting INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study
Condition: Glioblastoma Multiforme
Intervention: Radiation: Intraoperative Radiotherapy (Applicator Surface Dose: 20-40 Gy)
40 Recruiting Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
Conditions: Glioma;   Glioblastoma;   Glioblastoma Multiforme
Intervention: Drug: FDOPA PET-CT

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years